Product Details
Synonyms
CD79b, B29, IGB, Ig-beta
Source
Mouse CD79B Protein, His Tag (CDB-M52H4) is expressed from human 293 cells (HEK293). It contains AA Val 26 - Asp 158 (Accession # P15530-1).
Predicted N-terminus: Val 26
Request for sequenceMolecular Characterization

Other Tags and Version Biotin & Other Labeled Version
This protein carries a polyhistidine tag at the C-terminus.
The protein has a calculated MW of 17.0 kDa. The protein migrates as 28-38 kDa under reducing (R) condition (SDS-PAGE) due to glycosylation.
Endotoxin
Less than 0.01 EU per μg by the LAL method / rFC method.
Purity
>90% as determined by SDS-PAGE.
Formulation
Lyophilized from 0.22 μm filtered solution in PBS, 0.2 M Arginine, pH7.4 with trehalose as protectant.
Contact us for customized product form or formulation.
Reconstitution
Please see Certificate of Analysis for specific instructions.
For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.
Shipping and Storage
This product is shipped at ambient temperature.
For long term storage, the product should be stored at lyophilized state at -20°C or lower.
Please avoid repeated freeze-thaw cycles.
This product is stable after storage at:
- -20°C to -70°C for 12 months in lyophilized state;
- -70°C for 3 months under sterile conditions after reconstitution.
ACRO Quality Management System
Kunden haben auch angesehen
Data Display
SDS-PAGE

Mouse CD79B Protein, His Tag on SDS-PAGE under reducing (R) condition. The gel was stained with Coomassie Blue. The purity of the protein is greater than 90%.
SEC-MALS

The purity of Mouse CD79B Protein, His Tag (Cat. No. CDB-M52H4) is more than 85% and the molecular weight of this protein is around 25-40 kDa verified by SEC-MALS.
Report
User Reviews Publish Comment

Background Introduction
Frontier Progress
- English Name:
B-cell antigen receptor complex-associated protein beta chain
- Category:
- Listed Drugs Count:
1 Details
- Clinical Drugs Count:
9 Details
- Highest R&D Stage:
Approved



















